Received May 22, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
He reported experiencing chills about 6 hours after both doses of Shingrix.; This non-serious case was reported by a nurse via sales rep and described the occurrence of chills in a adult male patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, 6 hrs after receiving Shingrix, the patient experienced chills (Verbatim: He reported experiencing chills about 6 hours after both doses of Shingrix.). The outcome of the chills was not reported. It was unknown if the reporter considered the chills to be related to Shingrix. It was unknown if the company considered the chills to be related to Shingrix. Linked case(s) involving the same patient: US2025AMR063165 Additional Information: GSK Receipt Date: 20-MAY-2025 The reporter reported that the patient took both doses of Shingrix. He reported experiencing chills about 6 hours after both doses of Shingrix. This case is linked with US2025AMR063165, reported by same reporter.